BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29542338)

  • 1. Affinity enrichment for mass spectrometry: improving the yield of low abundance biomarkers.
    Kim B; Araujo R; Howard M; Magni R; Liotta LA; Luchini A
    Expert Rev Proteomics; 2018 Apr; 15(4):353-366. PubMed ID: 29542338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recent advances in glycopeptide enrichment and mass spectrometry data interpretation approaches for glycoproteomics analyses].
    Liu L; Qin H; Ye M
    Se Pu; 2021 Oct; 39(10):1045-1054. PubMed ID: 34505426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Hydrogel Nanoparticles for the Capture, Concentration, and Preservation of Low-Abundance Biomarkers.
    Magni R; Luchini A
    Methods Mol Biol; 2017; 1606():103-113. PubMed ID: 28501996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Cancer Biomarker Discovery Using DIA-MS Proteomic Analysis of EVs from Peripheral Blood.
    Espejo C; Lyons B; Woods GM; Wilson R
    Methods Mol Biol; 2023; 2628():127-152. PubMed ID: 36781783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgY14 and SuperMix immunoaffinity separations coupled with liquid chromatography-mass spectrometry for human plasma proteomics biomarker discovery.
    Shi T; Zhou JY; Gritsenko MA; Hossain M; Camp DG; Smith RD; Qian WJ
    Methods; 2012 Feb; 56(2):246-53. PubMed ID: 21925605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined tissue and fluid proteomics with Tandem Mass Tags to identify low-abundance protein biomarkers of disease in peripheral body fluid: An Alzheimer's Disease case study.
    Russell CL; Heslegrave A; Mitra V; Zetterberg H; Pocock JM; Ward MA; Pike I
    Rapid Commun Mass Spectrom; 2017 Jan; 31(2):153-159. PubMed ID: 27813239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced sensitivity and multiplexing with 2D LC/MRM-MS and labeled standards for deeper and more comprehensive protein quantitation.
    Percy AJ; Simon R; Chambers AG; Borchers CH
    J Proteomics; 2014 Jun; 106():113-24. PubMed ID: 24769237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
    Smith JG; Gerszten RE
    Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamer microarray mediated capture and mass spectrometry identification of biomarker in serum samples.
    Ahn JY; Lee SW; Kang HS; Jo M; Lee DK; Laurell T; Kim S
    J Proteome Res; 2010 Nov; 9(11):5568-73. PubMed ID: 20806970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bottleneck in the cancer biomarker pipeline and protein quantification through mass spectrometry-based approaches: current strategies for candidate verification.
    Makawita S; Diamandis EP
    Clin Chem; 2010 Feb; 56(2):212-22. PubMed ID: 20007861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogel nanoparticle harvesting of plasma or urine for detecting low abundance proteins.
    Magni R; Espina BH; Liotta LA; Luchini A; Espina V
    J Vis Exp; 2014 Aug; (90):e51789. PubMed ID: 25145492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle technology: addressing the fundamental roadblocks to protein biomarker discovery.
    Luchini A; Fredolini C; Espina BH; Meani F; Reeder A; Rucker S; Petricoin EF; Liotta LA
    Curr Mol Med; 2010 Mar; 10(2):133-41. PubMed ID: 20196732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic analysis of eluted fraction of plasma post immunoaffinity depletion: implications in biomarker discovery.
    Yadav AK; Bhardwaj G; Basak T; Kumar D; Ahmad S; Priyadarshini R; Singh AK; Dash D; Sengupta S
    PLoS One; 2011; 6(9):e24442. PubMed ID: 21931718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Two-Dimensional Affinity Capture and Separation Mini-Platform for the Isolation, Enrichment, and Quantification of Biomarkers and Its Potential Use for Liquid Biopsy.
    Guzman NA; Guzman DE
    Biomedicines; 2020 Jul; 8(8):. PubMed ID: 32751506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample preparation for detection of low abundance proteins in human plasma using ultra-high performance liquid chromatography coupled with highly accurate mass spectrometry.
    Seong Y; Yoo YS; Akter H; Kang MJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():272-280. PubMed ID: 28649027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular weight protein enrichment on mesoporous silica thin films for biomarker discovery.
    Fan J; Gallagher JW; Wu HJ; Landry MG; Sakamoto J; Ferrari M; Hu Y
    J Vis Exp; 2012 Apr; (62):. PubMed ID: 22546927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy.
    Qian WJ; Kaleta DT; Petritis BO; Jiang H; Liu T; Zhang X; Mottaz HM; Varnum SM; Camp DG; Huang L; Fang X; Zhang WW; Smith RD
    Mol Cell Proteomics; 2008 Oct; 7(10):1963-73. PubMed ID: 18632595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass Spectrometry-Based Chemical and Enzymatic Methods for Global Analysis of Protein Glycosylation.
    Xiao H; Suttapitugsakul S; Sun F; Wu R
    Acc Chem Res; 2018 Aug; 51(8):1796-1806. PubMed ID: 30011186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics Methodologies: The Search of Protein Biomarkers Using Microfluidic Systems Coupled to Mass Spectrometry.
    De Figueiredo I; Bartenlian B; Van der Rest G; Pallandre A; Halgand F
    Proteomes; 2023 May; 11(2):. PubMed ID: 37218924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker discovery in serum/plasma using surface enhanced laser desorption ionization time of flight (SELDI-TOF) mass spectrometry.
    Ndao M
    Methods Mol Biol; 2012; 818():67-79. PubMed ID: 22083816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.